Back
Mineralys Therapeutics 10K Form
Sell
38
MLYS
Mineralys Therapeutics
Last Price:
$12.74
Seasonality Move:
51.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MLYS News And Ratings
See the #1 stock for the next 7 days that we like better than MLYS
MLYS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-50.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.76 |
| Price / Book: | 2.68 |
Profitability
| EPS (TTM): | -3.29000 |
|---|---|
| Net Income (TTM): | $-153.3M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Mineralys Therapeutics Earnings Forecast
Key Mineralys Therapeutics Financial Ratios
-
The Interest Expense is -0.14% of Operating Income.
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Mineralys Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MLYS |
| Website: | mineralystx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MLYS Technical Analysis vs Fundamental Analysis
Sell
38
Mineralys Therapeutics (MLYS)
is a Sell
Is Mineralys Therapeutics a Buy or a Sell?
-
Mineralys Therapeutics stock is rated a SellThe current Mineralys Therapeutics [MLYS] share price is $12.75. The Score for MLYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.